This COVID-19 roundup includes coverage of the combination of amubarvimab and romlusevimab to manage COVID-19 infection, the association between COVID-19 and incident diabetes, and the effectiveness of...
This COVID-19 roundup includes coverage of the FDA’s simpler vaccination schedule and authorization of new treatment, decline in pediatric asthma diagnoses during pandemic, and a new treatment combination...
Researchers aimed to determine the risk profile of individuals without HIV who were seeking vaccination against mpox and if these patients would benefit from HIV pre-exposure prophylaxis use.
Researchers determined the predictive value of urine point-of-care tenofovir antibody test and compared the results against self-reported PrEP use and TFV-diphosphate levels in dried blood spots. Their...
This COVID-19 roundup includes coverage of the FDA’s amendment to its emergency use authorization of the Pfizer-BioNTech booster for pediatric patients, acute myocardial infection deaths rose during omicron...
Researchers evaluated the impact an intensified dose of dolutegravir had on patients living with HIV. Their research was presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2023...
The USPSTF has released a reaffirmation of their recommendations for screening for genital herpes infection in adolescents, adults, and pregnant persons.
To better understand the relationship between vaccination and PASC risk in this patient population, researchers utilized the TriNetX health research database. Data from more than 3 million adults who tested...
This COVID-19 roundup includes research on an alternative therapy to nirmatrelvir-ritonavir, a vaccine regimen that protects pregnant women and infants against certain variants, pegylated interferon lambda...
